CEL Net Receivables from 2010 to 2026

CVM Stock  USD 4.56  0.17  3.87%   
CEL SCI Net Receivables yearly trend continues to be very stable with very little volatility. Net Receivables is likely to grow to about -1.7 M this year. During the period from 2010 to 2026, CEL SCI Net Receivables quarterly data regression pattern had sample variance of 1.2 T and median of  62,765. View All Fundamentals
 
Net Receivables  
First Reported
1991-09-30
Previous Quarter
-2.1 M
Current Value
-2.3 M
Quarterly Volatility
480.9 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check CEL SCI financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CEL SCI's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.7 M, Interest Expense of 783.6 K or Selling General Administrative of 5.5 M, as well as many indicators such as Price To Sales Ratio of 861, Dividend Yield of 0.0762 or PTB Ratio of 2.0. CEL financial statements analysis is a perfect complement when working with CEL SCI Valuation or Volatility modules.
  
Build AI portfolio with CEL Stock
Check out the analysis of CEL SCI Correlation against competitors.
Evaluating CEL SCI's Net Receivables across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into CEL SCI Corp's fundamental strength.

Latest CEL SCI's Net Receivables Growth Pattern

Below is the plot of the Net Receivables of CEL SCI Corp over the last few years. It is CEL SCI's Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CEL SCI's overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

CEL Net Receivables Regression Statistics

Arithmetic Mean(536,100)
Geometric Mean335,990
Coefficient Of Variation(202.19)
Mean Deviation976,855
Median62,765
Standard Deviation1,083,936
Sample Variance1.2T
Range3.1M
R-Value(0.86)
Mean Square Error333.6B
R-Squared0.73
Significance0.000011
Slope(183,877)
Total Sum of Squares18.8T

CEL Net Receivables History

2026-1.7 M
2025-1.8 M
2021-2 M
201954.9 K
201862.8 K
2017118.7 K
2016218.5 K

About CEL SCI Financial Statements

CEL SCI investors utilize fundamental indicators, such as Net Receivables, to predict how CEL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables-1.8 M-1.7 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether CEL SCI Corp is a strong investment it is important to analyze CEL SCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CEL SCI's future performance. For an informed investment choice regarding CEL Stock, refer to the following important reports:
Check out the analysis of CEL SCI Correlation against competitors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Biotechnology sector continue expanding? Could CEL diversify its offerings? Factors like these will boost the valuation of CEL SCI. Projected growth potential of CEL fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CEL SCI data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(6.27)
Revenue Per Share
0.001
Quarterly Revenue Growth
(0.63)
Return On Assets
(0.60)
Return On Equity
(2.12)
Understanding CEL SCI Corp requires distinguishing between market price and book value, where the latter reflects CEL's accounting equity. The concept of intrinsic value - what CEL SCI's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push CEL SCI's price substantially above or below its fundamental value.
It's important to distinguish between CEL SCI's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CEL SCI should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, CEL SCI's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.